AstraZeneca PLC (AZN) : "They have gotten their act together and I'm saying buy," said Jim Cramer to a caller during Tuesday's "Lightning Round" segment of Mad Money. Let's check out the charts of this maker of pharmaceutical and biotechnology products.
More from Investing
RL is among many companies who are trying to recreate themselves.
The pockets of strong movement are very narrow right now.
With a month to go for these portfolios, the Active version is outperforming the Passive one, though both are crushing their Russell kindred.